3/12
02:35 pm
glue
Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE) is now covered by analysts at Lifesci Capital. They set an "outperform" rating and a $19.00 price target on the stock.
Low
Report
Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE) is now covered by analysts at Lifesci Capital. They set an "outperform" rating and a $19.00 price target on the stock.
3/11
07:00 am
glue
Monte Rosa Therapeutics to Present Pipeline Update and Release Fourth Quarter and Full Year 2024 Financial Results on March 20, 2025
Low
Report
Monte Rosa Therapeutics to Present Pipeline Update and Release Fourth Quarter and Full Year 2024 Financial Results on March 20, 2025
2/24
07:00 am
glue
Monte Rosa Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference
Medium
Report
Monte Rosa Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference
1/10
07:00 am
glue
Monte Rosa Therapeutics Provides Corporate Update and Key Anticipated Milestones for 2025
Medium
Report
Monte Rosa Therapeutics Provides Corporate Update and Key Anticipated Milestones for 2025
1/6
07:00 am
glue
Monte Rosa Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Medium
Report
Monte Rosa Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
12/19
07:42 am
glue
Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE) was downgraded by analysts at Wells Fargo & Company from an "overweight" rating to an "equal weight" rating. They now have a $11.00 price target on the stock, down previously from $14.00.
Medium
Report
Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE) was downgraded by analysts at Wells Fargo & Company from an "overweight" rating to an "equal weight" rating. They now have a $11.00 price target on the stock, down previously from $14.00.
12/13
07:07 am
glue
Monte Rosa Therapeutics Appoints Dr. Eric A. Hughes to Board of Directors [Yahoo! Finance]
Medium
Report
Monte Rosa Therapeutics Appoints Dr. Eric A. Hughes to Board of Directors [Yahoo! Finance]
12/13
07:00 am
glue
Monte Rosa Therapeutics Appoints Dr. Eric A. Hughes to Board of Directors
Medium
Report
Monte Rosa Therapeutics Appoints Dr. Eric A. Hughes to Board of Directors